RASSF1C modulates the expression of a stem cell renewal gene, PIWIL1

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Reeves, Mark E ^a,b   Baldwin, Melissa L ^a   Aragon, Robert ^a,b   Baldwin, Scott ^a,b   Chen, Shin Tai ^a   Li, Xinmin ^c   Mohan, Subburaman ^a   Amaar, Yousef G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ERK1 2; Gene expression; PIWIL1; RASSF1C; RASSF1C target genes

Indexed keywords

2 (2 CHLORO 4 IODOANILINO) N CYCLOPROPYLMETHOXY 3,4 DIFLUOROBENZAMIDE; 2-(2-CHLORO-4-IODOPHENYLAMINO)-N-CYCLOPROPYLMETHOXY-3,4-DIFLUOROBENZAMIDE; ARGONAUTE PROTEIN; BENZAMIDE DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; PIWIL1 PROTEIN, HUMAN; RASSF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

APOPTOSIS; ARTICLE; CANCER STEM CELL; CELL CYCLE; CELL LINE; CELL PROLIFERATION; DNA MICROARRAY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; ARGONAUTE PROTEINS; BENZAMIDES; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL CYCLE; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEINS;

EID: 84861000502     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-239     Document Type: Article

References (36)

1. Cancer statistics, 2010. A Jemal, R Siegel, J Xu, E Ward, CA Cancer J Clin 2010 60 277 300 10.3322/caac.20073 20610543
2. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. DG Burbee, E Forgacs, S Zochbauer-Muller, et al. J Natl Cancer Inst 2001 93 691 699 10.1093/jnci/93.9.691 11333291
3. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinoma. R Dammann, T Takahashi, G Pfeifer, Oncogene 2001 20 3563 3567 10.1038/sj.onc.1204469 11429703
4. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast, and ovarian tumors. A Agathanggelou, S Honorio, DP Macartney, et al. Oncogene 2001 20 1509 1518 10.1038/sj.onc.1204175 11313894
5. Identification of novel gene expression targets for Ras association domain family 1(RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. A Agathanggelou, I Bieche, J Ahmed-Choudhury, et al. Cancer Res 2003 63 5344 5351 14500366
6. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. R Dammann, C Li, JH Yoon, PL Chin, S Bates, GP Pfeifer, Nat Genet 2000 25 315 319 10.1038/77083 10888881
7. The candidate tumor suppressor gene, RASS1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. K Dreijerink, E Braga, I Kuzmin, et al. Proc Natl Acad Sci USA 2001 98 7504 7509 10.1073/pnas.131216298 11390984
8. Tumor Susceptibility of RASSF1A Knockout Mice. S Tommasi, R Dammann, Z Zhang, et al. Cancer Res 2005 65 92 98 15665283
9. Frequent hypermethylation of the RASSF1A gene in prostate cancer. L Liu, JH Yoon, R Dammann, GP Pfeifer, Oncogene 2002 21 6835 6840 10.1038/sj.onc. 1205814 12360410
10. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. MD Vos, CA Ellis, A Bell, MJ Birrer, GJ Clark, J Biol Chem 2000 275 35669 35672 10.1074/jbc.C000463200 10998413
11. Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene. J Li, F Wang, A Protopopov, et al. Oncogene 2004 23 5941 5949 10.1038/sj.onc.1207789 15208682
12. A role for the RASSF1A tumor suppressor in the regulation of tubulin polymerization and genomic stability. MD Vos, A Martinez, C Elam, et al. Cancer Res 2004 64 4244 4250 10.1158/0008-5472.CAN-04-0339 15205337
13. Release of RASSF1C from the nucleus by Daxx degradation links DNA damage and SAPK/JNK activation. D Kitagawa, H Kajiho, T Negishi, et al. EMBO J 2006 25 3286 3297 10.1038/sj.emboj.7601212 16810318
14. Ras-association domain family 1C protein promotes breast cancer cell migration and attenuates apoptosis. ME Reeves, SW Baldwin, ML Baldwin, ST Chen, JM Moretz, RJ Aragon, X Li, DD Strong, S Mohan, YG Amaar, BMC Cancer 2010 Oct 18 10 562 10.1186/1471-2407-10-562
15. Ras association domain family 1C protein stimulates human lung cancer cell proliferation. YG Amaar, MG Minera, LK Hatran, DD Strong, S Mohan, ME Reeves, Am J Physiol Lung Cell Mol Physiol 2006 291 1185 1190 10.1152/ajplung.00072.2006
16. RASSF1C, an isoform of the tumor suppressor RASSF1A, promotes the accumulation of beta-catenin by interacting with betaTrCP. E Estrabaud, I Lassot, G Blot, et al. Cancer Res 2007 67 1054 1061 10.1158/0008-5472.CAN-06- 2530 17283138
17. RAS association domain family protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation. YG Amaar, DJ Baylink, S Mohan, J Bone Miner Res 2005 20 1430 1439 10.1359/JBMR.050311 16007340
18. Insulin-like growth factor binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). YG Amaar, G Thompson, TA Linkhart, ST Chen, DJ Baylink, S Mohan, J Biol Chem 2002 277 12053 12060 10.1074/jbc. M110872200 11821401
19. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C (T)) Method. KJ Livak, TD Schmittgen, Methods 2001 25 402 408 10.1006/meth.2001.1262 11846609
20. Model-based analysis of oligonucleotide arrays: Expression index computation and outlier detection. C Li, WH Wong, Proc Natl Acad Sci USA 2001 98 31 36 10.1073/pnas.98.1.31 11134512
21. Stem cell-associated genes are extremely poor prognostic factors for soft-tissue sarcoma patients. H Taubert, P Würl, T Greither, M Kappler, M Bache, F Bartel, A Kehlen, C Lautenschläger, LC Harris, D Kaushal, S Füssel, A Meye, A Böhnke, H Schmidt, HJ Holzhausen, S Hauptmann, Oncogene 2007 26 7170 7174 10.1038/sj.onc.1210530 17525744
22. Expression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcoma. H Taubert, T Greither, D Kaushal, P Würl, M Bache, F Bartel, A Kehlen, C Lautenschläger, L Harris, K Kraemer, A Meye, M Kappler, H Schmidt, HJ Holzhausen, S Hauptmann, Oncogene 2007 26 1098 1100 10.1038/sj.onc.1209880 16953229
23. Expression of hiwi gene in human gastric cancer was associated with proliferation of cancer cells. X Liu, Y Sun, J Guo, H Ma, J Li, B Dong, G Jin, J Zhang, J Wu, L Meng, C Shou, Int J Cancer 2006 118 1922 1929 10.1002/ijc.21575 16287078
24. The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. LF Grochola, T Greither, H Taubert, P Möller, U Knippschild, A Udelnow, D Henne-Bruns, P Würl, Br J Cancer 2008 99 1083 1088 10.1038/sj.bjc.6604653 18781170
25. ALDH1A1 and ALDH3A1 expression in lung cancers: Correlation with histologic type and potential precursors. M Patel, L Lu, DS Zander, L Sreerama, D Coco, JS Moreb, Lung Cancer 2008 59 340 349 10.1016/j.lungcan.2007.08.033 17920722
26. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. N Sunaga, K Miyajima, M Suzuki, et al. Cancer Res 2004 64 4277 4285 10.1158/0008-5472.CAN-03-3941 15205342
27. Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. S Kikuchi, D Yamada, T Fukami, et al. Clin Cancer Res 2005 11 2954 2961 10.1158/1078-0432.CCR-04-2206 15837747
28. Krüppel-like factor 4 exhibits antiapoptotic activity following gamma-radiation-induced DNA damage. AM Ghaleb, JP Katz, KH Kaestner, JX Du, VW Yang, Oncogene 2007 26 2365 2373 10.1038/sj.onc.1210022 17016435
29. Enhanced RASGEF1A expression is involved in the growth and migration of intrahepatic cholangiocarcinoma. K Ura, K Obama, S Satoh, Y Sakai, Y Nakamura, Y Furukawa, Clin Cancer Res 2006 12 6611 6616 10.1158/1078-0432.CCR-06-0783 17121879
30. Polo-like kinase 2 gene expression is regulated by the orphan nuclear receptor estrogen receptor-related receptor gamma (ERRgamma). YY Park, SH Kim, YJ Kim, et al. Biochem Biophys Res Comm 2007 362 107 113 10.1016/j.bbrc.2007.07. 170 17706602
31. ABC transporters as phenotypic markers and functional regulators of stem cells. KD Bunting, Stem Cells 2002 20 11 20 10.1002/stem.200011 11796918
32. Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. LS Chow, CW Lam, SY Chan, et al. Oncogene 2006 25 310 316 16116475
33. Identification of bronchioalveolar stem cells in normal lung and lung cancer. CF Kim, EL Jackson, AE Woolfenden, et al. Cell 2005 121 823 835 10.1016/j.cell.2005.03.032 15960971
34. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. MM Ho, AV Ng, S Lam, JY Hung, Cancer Res 2007 67 4827 4833 10.1158/0008-5472.CAN-06-3557 17510412
35. Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. G Pelosi, C Fumagalli, M Trubia, A Sonzogni, N Rekhtman, P Maisonneuve, D Galetta, L Spaggiari, G Veronesi, A Scarpa, G Malpeli, G Viale, Anticancer Res 2010 30 4269 4281 21036752
36. Methylation-associated down-regulation of RASSF1A and up-regulation of RASSF1C in pancreatic endocrine tumors. G Malpeli, E Amato, M Dandrea, C Fumagalli, V Debattisti, L Boninsegna, G Pelosi, M Falconi, A Scarpa, BMC Cancer 2011 11 351 10.1186/1471-2407-11-351 21838870